Global Duchenne Muscular Dystrophy Market

Download free Sample

According to the latest research, the global Duchenne Muscular Dystrophy market size was valued at USD 1726.0 million in 2022 and is expected to expand at a CAGR of 43.02% during the forecast period, reaching USD 14772.0 million by 2028.

In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys' respiratory and cardiac muscles are also affected and for most boys, respiratory and cardiac failure are major causes of death, often prevalent by the age of 20.

This report elaborates on the market size, market characteristics, and market growth of the Duchenne Muscular Dystrophy industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Duchenne Muscular Dystrophy. The report also introduces players in the industry from the perspective of the value chain and looks into the leading companies.

Key Points this Global Duchenne Muscular Dystrophy Market Report Include:
Market Size Estimates: Duchenne Muscular Dystrophy market size estimation in terms of revenue and sales from 2018-2028
Market Dynamic and Trends: Duchenne Muscular Dystrophy market drivers, restraints, opportunities, and challenges
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Duchenne Muscular Dystrophy market
Segment Market Analysis: Duchenne Muscular Dystrophy market revenue and sales by type and by application from 2018-2028
Regional Market Analysis: Duchenne Muscular Dystrophy market situations and prospects in major and top regions and countries
Duchenne Muscular Dystrophy Market

Competitive Landscape

and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product/service profile and recent development/updates, etc.
Duchenne Muscular Dystrophy Industry Chain: Duchenne Muscular Dystrophy market raw materials & suppliers, manufacturing process, distributors by region, downstream customers
Duchenne Muscular Dystrophy Industry News, Policies by regions
Duchenne Muscular Dystrophy Industry Porters Five Forces Analysis

Key players in the global Duchenne Muscular Dystrophy market are covered in Chapter 2:
Bristol-Myers Squibb
Pfizer
Italfarmaco
Sarepta Therapeutics
Santhera Pharmaceuticals
PTC Therapeutics

In Chapter 6 and Chapter 9, on the basis of types, the Duchenne Muscular Dystrophy market from 2018 to 2028 is primarily split into:
Exondys 51
Emflaza
Translarna

In Chapter 7 and Chapter 10, on the basis of applications, the Duchenne Muscular Dystrophy market from 2018 to 2028 covers:
Hospitals
Clinics
Home Care

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions from 2018 to 2028 are covered in Chapter 8 and Chapter 11:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others

In summary, this report relies on sources from both primary and secondary, combines comprehensive quantitative analysis with detailed qualitative analysis, and pictures the market from a macro overview to micro granular segment aspects. Whatever your role in this industry value chain is, you should benefit from this report with no doubt.

Chapter Outline
This report consists of 12 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:

Chapter 1 first introduces the product overview, market scope, product classification, application, and regional division, and then summarizes the global Duchenne Muscular Dystrophy market size in terms of revenue, sales volume, and average price.

Chapter 2 analyzes the main companies in the Duchenne Muscular Dystrophy industry, including their main businesses, products/services, sales, prices, revenue, gross profit margin, and the latest developments/updates.

Chapter 3 is an analysis of the competitive environment of Duchenne Muscular Dystrophy market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the market concentration ratio in 2022 and the players' M&A and expansion in recent years.

Chapter 4 is an analysis of the Duchenne Muscular Dystrophy industrial chain, including raw material analysis, manufacturing cost structure, distributors, and major downstream buyers.

Chapter 5 focuses on Duchenne Muscular Dystrophy market dynamics and marketing strategy analysis, which include opportunities, challenges, industry development trends under inflation, industry news and policies analyzed by region, Porter's Five Forces analysis, as well as direct and indirect marketing, and the development trends of marketing channels.

Chapters 6-8 have segmented the Duchenne Muscular Dystrophy market by type, application, and region, with a focus on sales and value from 2018 to 2023 from both vertical and horizontal perspectives.

Chapters 9-11 provide detailed Duchenne Muscular Dystrophy market forecast data for 2023-2028, broken down by type and application, region, and major countries to help understand future growth trends.

Chapter 12 concludes with an explanation of the data sources and research methods. Verify and analyze through preliminary research to obtain final quantitative and qualitative data.